Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P1232: A Novel Inflammatory Bowel Disease Registry Powered by Artificial Intelligence and Natural Language ProcessingECCO'25
Year: 2025
Authors: Liu, J.(1,2,3)*;Massaro, C.(4);Cruz, E.(3);Kalisky, I.(2,3);Lunken, G.(3,4);Leung, Y.(2,3);Bressler, B.(2,3);Rosenfeld, G.(2,3);
(1)University of Montreal Hospital Centre CHUM, Gastroenterology, Montreal, Canada;(2)St. Paul's Hospital, Gastroenterology, Vancouver, Canada;(3)IBD Centre of BC, Gastroenterology, Vancouver, Canada;(4)BC Children’s Hospital Research Institute, Pediatrics, Vancouver, Canada;
P1233: Socio- demographic determinants of fatigue in patients with inflammatory bowel disease in remission: SOFA studyECCO'25
Year: 2025
Authors: Ferrari, T.(1)*;Hupe, M.(2);Altwegg, R.(3);Nancey, S.(4);Riviere, P.(5);Costentin, C.(1);Mathieu, N.(1);
(1)CHU Grenoble - Michallon Hospital, Isere, Grenoble, France;(2)CHU Grenoble- Michallon Hospital, Isere, Grenoble, France;(3)CHU Montpellier, Herault, Montpellier, France;(4)CHU Lyon, Rhone, Lyon, France;(5)CHU Bordeaux, Gironde, Bordeaux, France;

1- Anyane-Yeboa A, Quezada S, Rubin DT, Balzora S. The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022;20(11):2427-2434. doi:10.1016/j.cgh.2022.03.011
2- Amiot A, Chaibi S, Bouhnik Y, et al. Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID. J Crohns Colitis. 2023;17(9):1418-1425. doi:10.1093/ecco-jcc/jjad060
3- Vaucher P, Bischoff T, Diserens EA, et al. Detecting and measuring deprivation in primary care: development, reliability and validity of a self-reported questionnaire: the DiPCare-Q. BMJ Open. 2012;2(1):e000692. doi:10.1136/bmjopen-2011-000692
4- Rascle N, Bruchon-Schweitzer M. SHORT FORM OF SARASON’S SOCIAL SUPPORT QUESTIONNAIRE: FRENCH ADAPTATION AND VALIDATION ’.

P1234: Inflammatory Bowel Disease Trends and Advanced Therapy Utilization: Insights from the UAEECCO'25
Year: 2025
Authors: Ahmed, H.A.(1)*;Swaid, T.K.(1);Alzaabi, M.N.(1);Khan, S.W.(1);Ali, A.B.A.A.(1);Tenaiji, K.S.A.A.(1);Alahmad, M.A.(1);Omar, N.M.(1);Ahmed, E.F.(1);Hosani, I.I.A.(1);Kumar, K.K.C.(1);Malik, T.A.(2);Quraishi, M.N.(1);
(1)Sheikh Shakhbout Medical City, Gastroenterology, Abu Dhabi, United Arab Emirates;(2)Mayo Clinic Arizona, Gastroenterology, Arizona, United States; SSMC
P1235: COlombian PrevaLence of Extraintestinal Manifestations in Inflammatory bowel disease in an adult and pediatric cohort after evaluation by a multidisciplinary group COLEMI – studyECCO'25
Year: 2025
Authors: Parra Izquierdo, V.(1,2,3)*;Frías-Ordoñez, J.(4);Puentes-Manosalva, F.(2,5);Sarmiento, F.(6,7);Garcia-Duperly, R.(2,8);Vargas, M.(2,9);Reyes, G.(2,10);Florez-Sarmiento, C.(2,11);Lobaton, T.(12);
(1)Hospital Internacional de Colombia, Gastroenterology and Rheumatology, Bucaramanga, Colombia;(2)Colombian Foundation for Inflammatory Bowel Disease - FUNEIICO, Inflammatory Bowel Disease, Bucaramanga, Colombia;(3)Group of Cellular and Molecular Immunology INMUBO- Universidad El Bosque, Immunology, Bogota, Colombia;(4)National University of Colombia, Gastroenterology, Bogotá, Colombia;(5)Union of Surgeons. ODO. Zentria Health - University of Caldas, Gastroenterology, Manizales, Colombia;(6)Hospital de La Misericordia, Pediatric Gastroenterology, Bogota, Colombia;(7)Colombian Foundation for Inflammatory Bowel Disease - FUNEIICO, Inflammatory Bowel Diseas, Bucaramanga, Colombia;(8)Fundacion Santa Fe de Bogotá, Coloproctology, Bogota, Colombia;(9)Gastrokids SAS, Pediatric Gastroenterology, Pereira, Colombia;(10)Fundacion Santa Fe de Bogota, Gastroenterology, Bogota, Colombia;(11)Hospital Internacional de Colombia, Gastroenterology, Bucaramanga, Colombia;(12)Universitair Ziekenhuis Ghent., Gastroenterology, Ghent, Belgium;
P1236: Temporal trends in obesity and its prognostic impact in Korean patients with inflammatory bowel diseaseECCO'25
Year: 2025
Authors: Hwang, S.W.(1)*;Kim, M.K.(1);Hong, S.W.(1);Park, S.H.(1);Yang, D.H.(1);Ye, B.D.(1);Byeon, J.S.(1);Myung, S.J.(1);Yang, S.K.(1);
(1)University of Ulsan College of Medicine- Asan Medical Center, Department of Gastroenterology, Seoul, Korea- Republic Of;


1.Nic Suibhne T, Raftery TC, McMahon O, et al. High prevalence of overweight and obesity in adults with Crohn's disease: associations with disease and lifestyle factors. J Crohns Colitis. 2013;7:e241-8

2.Singh S, Dulai PS, Zarrinpar A, et al. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017;14:110-21

3.Seminerio JL, Koutroubakis IE, Ramos-Rivers C, et al. Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21:2857-63.

P1237: Musculoskeletal involvement is frequent in bio-naïve patients with IBD initiating biological treatment– a prospective cohort studyECCO'25
Year: 2025
Authors: Vladimirova, N.(1)*;Zhao, M.(2);Ørnbjerg, L.M.(3);Møller, J.M.(4);Attauabi, M.(5);Nielsen, Y.J.W.(6);Saboori, S.(2);Burisch, J.(7);Østergaard, M.(8);
(1)Copenhagen University Hospital: Rigshospitalet- Glostrup, COPECARE- Copenhagen Center for Arthritis Research- Center for Rheumatology and Spine Diseases, Copenhagen, Denmark;(2)Copenhagen University Hospital – Amager and Hvidovre, Gastrounit- Medical Section, Copenhagen, Denmark;(3)Copenhagen University Hospital Rigshospitalet Glostrup, Copenhagen Center for Arthritis Research COPECARE- Center for Rheumatology and Spine Diseases, Copenhagen, Denmark;(4)Copenhagen University Hospital - Herlev and Gentofte-, Department of Radiology, Copenhagen, Denmark;(5)Copenhagen University Hospital - Herlev and Gentofte, Department of Gastroenterology and Hepatology, Copenhagen, Denmark;(6)Copenhagen University Hospital - Herlev and Gentofte, Department of Radiology, Copenhagen, Denmark;(7)Copenhagen University Hospital – Amager and Hvidovre, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Copenhagen, Denmark;(8)Copenhagen University Hospital Rigshospitalet Glostrup, Copenhagen Center for Arthritis Research COPECARE- Center for Rheumatology and Spine Diseases-, Copenhagen, Denmark;
P1238: Herpes Zoster Risk in Patients with Inflammatory Bowel Disease and Its Association with Medications Used: A Nationwide Population-Based Study in TaiwanECCO'25
Year: 2025
Authors: Tsai, M.J.(1)*;Kuo, T.H.(2);Lai, H.C.(3);Wu, Y.H.(4);Huang, P.J.(4);Cheng, K.S.(4);Chou, J.W.(4);
(1)China Medical University Hospital- Taichung- Taiwan- R.O.C, Department of Education, Taichung, Taiwan;(2)China Medical University Hospital- Taichung- Taiwan- R.O.C., Department of Education, Taichung, Taiwan;(3)School of Chinese Medicine- College of Chinese Medicine- China Medical University- Taichung- Taiwan- R.O.C., Graduate Institute of Chinese Medicine, Taichung, Taiwan;(4)China Medical University Hospital- Taichung- Taiwan- R.O.C., Center for Digestive Disease- Department of Internal Medicine, Taichung, Taiwan;

1. Singer D, Thompson-Leduc P, Gupta D, et al. Incidence and risk of herpes zoster in patients with ulcerative colitis and Crohn's disease in the USA. Gastroenterol Rep (Oxf) 2023;11:goad016. 
2. Côté-Daigneault J, Bessissow T, Nicolae MV, et al. Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study. Inflamm Bowel Dis 2019;25:914-918. 
3. Chang K, Lee HS, Kim YJ, et al. Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea. Clin Gastroenterol Hepatol 2018;16:1928-1936.e2. 
4. Long MD, Martin C, Sandler RS, et al. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013;37:420-429.

P1239: Microplastics are associated with biomarker of intestinal inflammation in a pilot analysis of the PLANET StudyECCO'25
Year: 2025
Authors: Lykkemark, J.(1);Picker, M.(2);Kim, T.(2);Nguyen, I.(2);Weinstein, K.(2);Chen, R.(2);Simon-Sánchez, L.(1);Lordachescu, L.(1);Torres, J.(3,4,5);Stone, J.(6);Bianco, A.(6);Shaw, L.(6);Tavella, N.(6);Jess, T.(7);Allin, K.(7,8);Peter, I.(2);Colombel, J.F.(9);Vianello, A.(1);Vollertsen, J.(1);Agrawal, M.(7,9)*;
(1)Aalborg University, Department of the Built Environment, Aalborg, Denmark;(2)Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, United States;(3)Hospital da Luz, Division of Gastroenterology, Lisboa, Portugal;(4)Universidade de Lisboa, Faculdade de Medicina, Lisboa, Portugal;(5)Hospital Beatriz Ângelo, Division of Gastroenterology, Loures, Portugal;(6)Icahn School of Medicine at Mount Sinai, Department of Obstetrics- Gynecology and Reproductive Science, New York, United States;(7)Aalborg University, Center for Molecular Prediction of Inflammatory Bowel Disease PREDICT- Department of Clinical Medicine, Copenhagen, Denmark;(8)Aalborg University Hospital, Department of Gastroenterology & Hepatology, Aalborg, Denmark;(9)Icahn School of Medicine at Mount Sinai, The Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States;
P1240: Overweight in patients with inflammatory bowel disease and the associated risk of malnutritionECCO'25
Year: 2025
Authors: Suarez Ferrer, C.J.(1)*;Cubillo Garcia, C.(2);Garcia-Rojas Pleite, C.(2);Rueda Garcia, J.L.(1);Martin Arraz, E.(1);Sanchez Azofra, M.(1);Poza Cordon, J.(1);Garcia Ramirez, L.(2);Noci Belda, J.(2);Martin-Arranz, M.D.(1);
(1)Hospital Universitario La Paz. IDIPaz, Gastroenterology, Madrid, Spain;(2)Hospital universitario La Paz, Gastroenterology, Madrid, Spain;
P1241: Identification and characterization of patients with Crohn's disease and complex perianal fistulas using Natural Language Processing and machine learning: INTUITION-CPF Study.ECCO'25
Year: 2025
Authors: García-Olmo, D.(1);Chaparro, M.(2)*;Marquez Mosquera, L.(3);González Argenté- , F.J.(4);Perez Calle, J.L.(5);Tomé Pizarro, M.(6);Aparicio, J.(6);Montoto, C.(6);Sánchez Guillén, L.(7);P Gisbert, J.(2);
(1)Hospital Universitario Fundación Jiménez Díaz, Department of Surgery, Madrid, Spain;(2)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-Princesa- Universidad Autónoma de Madrid UAM- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Gastroenterology Department, Madrid, Spain;(3)Hospital del Mar, IBD Unit, Barcelona, Spain;(4)Hospital Universitario Son Espases, Colorectal Surgery- Department of Surgery, Palma de Mallorca, Spain;(5)Hospital Universitario Fundación Alcorcón, Gastroenterology Department, Madrid, Spain;(6)Takeda, Medical Department, Madrid, Spain;(7)Elche University Hospital- Universidad Miguel Hernández, Colorectal Unit- Department of General Surgery, Elche Alicante, Spain;
P1242: Incidence of Acute Severe Ulcerative Colitis in a Changing Landscape of Increased Disease Prevalence and More Effective TherapiesECCO'25
Year: 2025
Authors: Nario, S.(1)*;Wu, M.(1,2);Tung, C.(1);Kiely, C.(1);
(1)Royal North Shore Hospital, Department of Gastroenterology, St Leonards, Australia;(2)University of Sydney, Northern Clinical School, Sydney, Australia;

1. Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17-30. doi:10.1016/S2468-1253(19)30333-4
2. Forbes AJ, Frampton CMA, Day AS, Kaplan GG, Gearry RB. The Epidemiology of Inflammatory Bowel Disease in Oceania: A Systematic Review and Meta-Analysis of Incidence and Prevalence. Inflamm Bowel Dis. Published online December 30, 2023. doi:10.1093/IBD/IZAD295
3. Dinesen LC, Walsh AJ, Protic MN, et al. The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010;4(4):431-437. doi:10.1016/J.CROHNS.2010.02.001
4. Sturm A, Maaser C, Calabrese E, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects. J Crohns Colitis. 2019;13(3):273-284. doi:10.1093/ECCO-JCC/JJY114

P1243: Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study in TaiwanECCO'25
Year: 2025
Authors: Kuo, T.(1)*;Tsai, M.J.(1);Chou, J.W.(2);Lai, H.C.(3);Wu, Y.H.(2);Huang, P.J.(2);Cheng, K.S.(2);
(1)China Medical University Hospital- Taichung- Taiwan- R.O.C., Department of Education, Taichung, Taiwan;(2)China Medical University Hospital- Taichung- Taiwan- R.O.C., Center for Digestive Disease- Department of Internal Medicine, Taichung, Taiwan;(3)China Medical University- Taichung- Taiwan- R.O.C., Graduate Institute of Chinese Medicine- School of Chinese Medicine- College of Chinese Medicine, Taichung, Taiwan;

References

1.Gordon H, Burisch J, Ellul P, et al. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis. 2024;18:1-37. doi:10.1093/ecco-jcc/jjad108.

P1244: Differential impact of appendectomy with appendiceal inflammation versus no inflammation on inflammatory bowel disease risk in a population-based cohortECCO'25
Year: 2025
Authors: Agrawal, M.(1,2)*;Hansen, A.V.(2);Harpaz, N.(3);Colombel, J.F.(1);Jess, T.(2,4);Allin, K.H.(2,4);
(1)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(2)Center for Molecular Prediction of Inflammatory Bowel Disease PREDICT- Aalborg University, Department of Clinical Medicine, Copenhagen, Denmark;(3)Icahn School of Medicine at Mount Sinai, Pathology, New York, United States;(4)Aalborg University Hospital, Department of Gastroenterology & Hepatology, Aalborg, Denmark;
P1245: Maternal intake of fish, dietary n-3 polyunsaturated fatty acids, and fish oil supplements during pregnancy and risk of early childhood Inflammatory Bowel Disease in the offspringECCO'25
Year: 2025
Authors: Brusco De Freitas, M.(1)*;Anneberg, O.M.(1);Frodi Olsen, S.(2,3,4);Vinkel Hansen, A.(1);Ahrendt Bjerregaard, A.(2,5);Ingi Halldórsson, Þ.(2,6);Jess, T.(1,7);
(1)Aalborg University, Department of Clinical Medicine, Copenhagen, Denmark;(2)Statens Serum Institute, Department of Epidemiology Research, Copenhagen, Denmark;(3)University of Copenhagen, Department of Public Health, Copenhagen, Denmark;(4)Harvard T.H. Chan School of Public Health, Department of Nutrition, Boston, United States;(5)Copenhagen University Hospitals – Bispebjerg and Frederiksberg, Centre for Clinical Research and Prevention, Copenhagen, Denmark;(6)University of Iceland, Faculty of Food Science and Nutrition, Reykjavik, Iceland;(7)Aalborg University Hospital, Department of Gastroenterology and Hepatology, Aalborg, Denmark;
P1246: Fatigue trajectory and the impact of disease course through the first year after diagnosis in patients with Inflammatory Bowel Disease (the IBSEN III study)ECCO'25
Year: 2025
Authors: Holten, K.I.A.(1,2)*;Bernklev, T.(1,3);Opheim, R.(4,5);Olsen, B.(1,6);Bengtson, M.B.(7);Ricanek, P.(8);Hovde, Ø.(9);Asak, Ø.(10);Boyar, R.(11);Johansen, I.(5,12);Torp, R.(13);Aabrekk, T.B.(14,15);Strande, V.(1,16);Frigstad, S.O.(17);Detlie, T.E.(1,18);Kristensen, V.A.(1,4);Hagen, M.(19);Henriksen, M.(2);Huppertz-Hauss, G.(20);Høivik, M.L.(1,4);Jelsness-Jørgensen, L.P.(2,21);
(1)Institute of Clinical Medicine- University of Oslo, Faculty of Medicine, Oslo, Norway;(2)Østfold Hospital Trust, Department of Gastroenterology, Sarpsborg, Norway;(3)Vestfold Hospital Trust, Department of Research and Development, Tønsberg, Norway;(4)Oslo University Hospital, Department of Gastroenterology, Oslo, Norway;(5)Institute of Health and Society- University of Oslo, Department of Public Health, Oslo, Norway;(6)Telemark Hospital Trust, Department of Gastroenterology, Skien, Norway;(7)Vestfold Hospital Trust, Department of Gastroenterology, Tønsberg, Norway;(8)Lovisenberg Diaconal Hospital, Department of Gastroenterology, Oslo, Norway;(9)Innlandet Hospital Trust, Department of Medicine, Gjøvik, Norway;(10)Innlandet Hospital Trust, Department of Gastroenterology, Lillehammer, Norway;(11)Diakonhjemmet Hospital, Department of Medicine, Oslo, Norway;(12)Østfold University College, Department of Health- Welfare and Organization, Fredrikstad, Norway;(13)Innlandet Hospital Trust, Medical department, Hamar, Norway;(14)Institute of Clinical Medicine- University of Oslo, Department of Gastroenterology, Oslo, Norway;(15)Vestfold Hospital Trust, Medical department, Tønsberg, Norway;(16)Unger-Vetlesen Institute- Lovisenberg Diaconal Hospital, Department of Internal medicine, Oslo, Norway;(17)Vestre Viken Hospital Trust, Department of Medicine, Bærum, Norway;(18)Akershus University Hospita, Department of Gastroenterology, Oslo, Norway;(19)Oslo Metropolitan University, Department of Public Health, Oslo, Norway;(20)Telemark Hospital, Department of Gastroenterology, Skien, Norway;(21)Østfold University College, Department of Health Sciences, Halden, Norway;
P1247: An argument for screening? Disordered eating patterns are highly prevalent in Inflammatory Bowel Disease (IBD)ECCO'25
Year: 2025
Authors: Grande, E.(1)*;Barnes, A.(2);Mountifield, R.(2);
(1)Flinders University of South Australia, College of Medicine and Public Health, Adelaide, Australia;(2)Southern Adelaide Local Health Network, Department of Gastroenterology, Adelaide, Australia;
P1248: Higher Life’s Essential 8 score is associated with reduced risk of IBD-related surgery and all-cause mortality among 3,232 individuals with inflammatory bowel disease in a prospective cohort studyECCO'25
Year: 2025
Authors: Jing, F.(1);Cao, Y.(1);Gong, Q.(2);Dan, L.(3);Zhu, Y.(4);Magro, F.(5);Fu, T.(6);Wang, X.(7);Chen, J.(8)*;
(1)The Third Xiangya Hospital of Central South University, Department of Gastroenterology, Changsha, China;(2)Central South University, Xiangya School of Medicine, Changsha, China;(3)Ruijin Hospital- Shanghai Jiao Tong University School of Medicine, Department of Gastroenterology, Shanghai, China;(4)Beijing Anzhen Hospital- Capital Medical University, Cardiology Department, Beijing, China;(5)Faculty of Medicine of the University of Porto, CINTESIS@RISE- Departmento, Porto, Portugal;(6)The Third Xiangya Hospital of Central South University- Affiliated Hangzhou First People's Hospital- Westlake University Medical College, Department of Gastroenterology, Hangzhou, China;(7)Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, China;(8)The Third Xiangya Hospital- Central South University, Department of Gastroenterology, Changsha, China;
P1249: Higher dietary glycemic index, but not glycemic load, is associated with increased risk of ulcerative colitis: a prospective cohort studyECCO'25
Year: 2025
Authors: Ye, S.(1);Fu, T.(2);Tu, Y.(3);Wellens, J.(4);Chen, X.(1);Larsson, S.C.(5);Sun, J.(6);Dan, L.(3);Wan, X.(1);Chen, J.(7)*;Magro, F.(8);
(1)The Third Xiangya Hospital of Central South University, Department of Gastroenterology, Changsha, China;(2)The Third Xiangya Hospital of Central South University- Affiliated Hangzhou First People's Hospital- Westlake University Medical College, Department of Gastroenterology, Hangzhou, China;(3)Ruijin Hospital- Shanghai Jiao Tong University School of Medicine, Department of Gastroenterology, Shanghai, China;(4)Translational Research Center for Gastrointestinal Disorders TARGID- Nuffield Department of Medicine- John Radcliffe Hospital, KU Leuven Department of Chronic Diseases and Metabolism- Translational Gastro-Intestinal Unit, Leuven, Belgium;(5)Karolinska Institutet- Stockholm- Sweden- Unit of Medical Epidemiology, Institute of Environmental Medicine, Uppsala, Sweden;(6)Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden;(7)The Third Xiangya Hospital- Central South University, Department of Gastroenterology, Changsha, China;(8)Faculty of Medicine of the University of Porto, CINTESIS@RISE- Departmento, Porto, Portugal;
P1250: Spondyloarthritis before and after inflammatory bowel disease diagnosis and risk factors: a temporal trends analysis in a population-based cohortECCO'25
Year: 2025
Authors: Agrawal, M.(1,2)*;Sorensen, C.(2);Poulsen, G.(2);Moghaddam, B.(3);Gulko, P.S.(3);Colombel, J.F.(1);Jess, T.(2,4);
(1)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(2)Center for Molecular Prediction of Inflammatory Bowel Disease PREDICT- Aalborg University, Department of Clinical Medicine, Copenhagen, Denmark;(3)Icahn School of Medicine at Mount Sinai, Division of Rheumatology, New York, United States;(4)Aalborg University Hospital, Department of Gastroenterology & Hepatology, Aalborg, Denmark;
P1251: A Care Pathway for Inflammatory Bowel Disease can Reduce Healthcare Costs and is Cost-EffectiveECCO'25
Year: 2025
Authors: Visser, E.(1,2)*;Oude Voshaar, A.M.(3);van Linschoten, R.(4);Bodelier, A.(5);Fitzpatrick, C.(6);de Jonge, V.(7);Vermeulen, H.(8);Verweij, E.(9);van der Wiel, S.(10);van der Horst, D.(11);van der Woude, C.J.(12);West, R.L.(1);van Noord, D.(1);
(1)Franciscus, Gastroenterology & Hepatology, Rotterdam, The Netherlands;(2)Erasmus MC, Gastroenterology & Hepatology, Rotterdam, The Netherlands;(3)Erasmus MC, Public Health, Rotterdam, The Netherlands;(4)Erasmus MC, Family Medicine, Rotterdam, The Netherlands;(5)Amphia Hospital, Gastroenterology & Hepatology, Breda, The Netherlands;(6)IJsselland Hospital, Gastroenterology & Hepatology, Rotterdam, The Netherlands;(7)Albert Schweitzer Hospital, Gastroenterology & Hepatology, Dordrecht, The Netherlands;(8)Ikazia Hospital, Gastroenterology & Hepatology, Rotterdam, The Netherlands;(9)Maasstad Hospital, Gastroenterology & Hepatology, Rotterdam, The Netherlands;(10)Reinier de Graaf Gasthuis, Gastroenterology & Hepatology, Delft, The Netherlands;(11)Crohn & Colitis NL, Crohn & Colitis NL, Woerden, The Netherlands;(12)Radboud UMC, Healthcare Related Education, Nijmegen, The Netherlands; Southwest Netherlands IBD Study Group